Complement Therapeutics GmbH
PrivateLast Round
Series A
Apr 17, 2023
Total Funding Raised
$84.36M
Company Overview
Complement Therapeutics GmbH is a clinical-stage biotechnology company that develops novel gene therapies and diagnostic platforms for diseases mediated by the complement system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Complement Therapeutics GmbH Comparables
Compare Complement Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceive Bio | 86% | |
| Oculogenex | 83% | |
| Aviceda Therapeutics | 78% | |
Complement Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 17, 2023 | ||||
| Seed | Feb 23, 2022 |
Complement Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A, Seed |
| Gimv | Series A |
| Seroba Life Sciences | Series A |
| Panakès Partners | Series A |
| Cambridge Innovation Capital | Series A |
| Hadean Ventures | Series A |
| BioGeneration Ventures | Series A, Seed |
Complement Therapeutics GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Complement Therapeutics GmbH's valuation, stock price, and market status.